Intas Pharma

Rediff.com » News » Intas Pharma

News for Intas Pharma

Business

Why Zydus is likely to continue with its outperformance

Even as most of its large-cap pharmaceutical peers have struggled to stay above water on the returns front, Zydus Lifesciences has been one of the big outperformers within the sector over the past......

PE/VC investments in pharma cos cross $1 bn mark

Fund managers said investors remained positive on the pharma manufacturing activity in India, which further strengthened during the Covid-19 period, on account of restrictions imposed on pharma......

'Famotidine may become the next HCQ for Covid-19'

Researchers at Northwell Health in New York are testing the effects on Famotidine (used in high intravenous doses) on Covid-19 patients as a potential treatment. After the hospital announced its......

Why Japan is betting big on Indian pharma cos

One reason Japan is betting highly on Indian pharma is that these companies have strong cash flows, low leverage and high debt capacity for medium to large sized acquisitions, report Sohini Das &......

Indian pharma firms working on new repurposed drug for Covid-19

Many companies globally are working on plasma research to develop and manufacture hyperimmune globulin therapies from plasma donations. Domestic drug firms are working on re-purposed drugs that......

Rediff News

Intas Pharma

News for Intas Pharma

Why Zydus is likely to continue with its outperformance

PE/VC investments in pharma cos cross $1 bn mark

'Famotidine may become the next HCQ for Covid-19'

Why Japan is betting big on Indian pharma cos

Indian pharma firms working on new repurposed drug for Covid-19

Top Coverage News

World Test Championship 2023

Manipur's Tragedy

IPL 2023

Sri Lanka's Tour of India 2023

GUJARAT, HIMACHAL GO TO POLLS